N

Nanjing Medlander Medical Technology Co Ltd
SSE:688273

Watchlist Manager
Nanjing Medlander Medical Technology Co Ltd
SSE:688273
Watchlist
Price: 41.81 CNY 2.83% Market Closed
Market Cap: ¥4.2B

Nanjing Medlander Medical Technology Co Ltd
Investor Relations

Nanjing Medlander Medical Technology Co., Ltd. engages in the research, development, production, and sale of pelvic floor rehabilitation products. The company is headquartered in Nanjing, Jiangsu and currently employs 511 full-time employees. The company went IPO on 2022-08-11. The firm's products mainly include pelvic floor and postpartum rehabilitation equipment, consumables and accessories, information products and others, including biostimulation feedback instruments, basin training instruments, basin biostimulation feedback instruments, vaginal electrodes, pelvic maintenance instruments and others. The firm's products are mainly used in obstetrics and gynecology, gynecology, pelvic floor rehabilitation centers, confinement centers, postpartum rehabilitation centers, mother and child centers and other professional institutions in medical institutions.

Show more
Loading
688273
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Ruijia Yang
Chairman of the Board & GM
No Bio Available
Ms. Ning Xu
Financial Director
No Bio Available
Mr. Bin Chen
Director & Deputy GM
No Bio Available
Mr. Zhihuai Shi
Deputy GM & Director
No Bio Available
Ms. Jiangning Chen
Deputy GM & Board Secretary
No Bio Available
Mr. Honglin Tu
Deputy General Manager
No Bio Available

Contacts

Address
JIANGSU
Nanjing
Building A2, No. 32, Fengzhan Road, Yuhuatai District
Contacts
+862569782957
www.medlander.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett